These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 18695904

  • 1. GFP image analysis in the mouse orthotopic bladder cancer model.
    De Velasco MA, Tanaka M, Anai S, Tomioka A, Nishio K, Uemura H.
    Oncol Rep; 2008 Sep; 20(3):543-7. PubMed ID: 18695904
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Whole-body fluorescent imaging of the growth and metastasis of GFP-expressing bladder tumors].
    Wu YD, Tan WL, Xie Y, Yu ZC, Zhao GZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):436-40. PubMed ID: 16624746
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: analysis in a preclinical survival model.
    Glaves D, Murray MK, Raghavan D.
    Clin Cancer Res; 1996 Aug; 2(8):1315-9. PubMed ID: 9816302
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q, Mahendran R, Esuvaranathan K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4522-8. PubMed ID: 14555526
    [Abstract] [Full Text] [Related]

  • 12. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
    Hadaschik BA, Jackson J, Fazli L, Zoubeidi A, Burt HM, Gleave ME, So AI.
    BJU Int; 2008 Aug 05; 102(5):610-6. PubMed ID: 18384625
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA, Zhang K, So AI, Fazli L, Jia W, Bell JC, Gleave ME, Rennie PS.
    Cancer Res; 2008 Jun 15; 68(12):4506-10. PubMed ID: 18559493
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.
    Zang Z, Mahendran R, Wu Q, Yong T, Esuvaranathan K.
    Int J Mol Med; 2004 Oct 15; 14(4):713-7. PubMed ID: 15375606
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
    Hadaschik BA, Black PC, Sea JC, Metwalli AR, Fazli L, Dinney CP, Gleave ME, So AI.
    BJU Int; 2007 Dec 15; 100(6):1377-84. PubMed ID: 17850390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.